Pediatr. praxi 2019; 20(5): 294-298 | DOI: 10.36290/ped.2019.058

Peroral isotretinoin in a treatment of acne

MUDr. Zuzana Nevoralová, Ph.D.
Akné poradna Jihlava, Nemocnice Jihlava

Acne is a polymorphic inflammatory disease of a pilosebaceous unit. Peroral isotretinoin belongs to the first non-aromatic generation
of retinoids and is the most effective medicine in acne treatment. It is indicated first of all for a therapy of severe and resistent
forms of acne. The therapy should by directed only by a dermatologist who is experienced in the treatment with this medicine.
Howecer, it is useful, pediatricians had a basic knowledge about this treatment. In the article basic informations about an effect,
indications and about the course of the treatment with peroral isotretinoin including a maintenance therapy are described.

Keywords: acne, treatment, isotretinoin, treatment recommendations

Published: November 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoralová Z. Peroral isotretinoin in a treatment of acne. Pediatr. praxi. 2019;20(5):294-298. doi: 10.36290/ped.2019.058.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Dréno B. What is new in the pathophyziology of acne, an overview. J Eur Acad Dermatol Venereol 2017; 31(Suppl. 5): 8-12. Go to original source... Go to PubMed...
    2. Plewig G, Melnik B, Chen W. Acne Classification and Disease Burden. In: Plewig G, Melnik B, Chen, W: Plewig and Kligman's Acne and Rosacea. 4rd ed. Springer Natur Switzerland AG 2019: 217-218. Go to original source...
    3. Nevoralová Z. Akné, in: Nevoralová Z., Rulcová J., Benáková B. Obličejové dermatózy, 2. přepracované a doplněné vydání. Mladá fronta 2018; 304s.
    4. Layton, AM. The use of isotretinoin in acne. Dermatoendocrinol, 2009; 1(3): 162-169. Go to original source... Go to PubMed...
    5. Rawlings AV. The molecular biology of retinoids and their receptors. In Webster, G. et al. Acne and its therapy. New York: Informa Healthcare 2007: 45-53. Go to original source...
    6. Landthales M., Kummermehr J., Wagner, A. et al. Inhibitory effects of 13-cis-retinoid acid on human sebaceous glands. Arch Dermatol Res 1980; 269: 297-309. Go to original source... Go to PubMed...
    7. Leyden JJ, Mc Ginley KJ, Foglia AN. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol 1986; 86(4): 390-393. Go to original source... Go to PubMed...
    8. Nast A, Dréno B, Bettoli V, et al. European Evidence-based (S3) Guidelines for the Treatment of Acne. J Eur Acad Dermatol Venereol, 2012; 26(Suppl. 1): 1-29. Go to original source... Go to PubMed...
    9. Gollnick HPM, et al. A consensus-based practical and daily guide for the treatment of acne patients. J Eur Acad Dermatol Venereol, 2016 epub. DOI: 10.1111/jdv.13675. Go to original source... Go to PubMed...
    10. Nevoralová Z. Izotretinoin v praxi. Mladá fronta 2012; 156s.
    11. Nevoralová Z. Novinky v léčbě perorálním izotretinoinem, Dermatol. praxi 1/2017; 11: 22-26. Go to original source...
    12. Aravilskaia E, Dreno B. The role of topical dermocosmetics in acne vulgaris. J Am Acad Dermatol 2016; 30: 926-935. Go to original source... Go to PubMed...
    13. Nevoralová Z. Udržovací léčba akné. Dermatol. praxi 2016; 10(1): 10-153. Go to original source...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.